Tuesday Sep 19, 2023
12:00 PM - 1:00 PM EDT
Elizabeth Witherspoon, NCBiotech
Send Email
Life sciences companies have an opportunity to build markets and categories for new medicines and medical products that promise better efficacy, safety, value and price. As these companies reach the proof-of-concept stage with their technologies, it is wise to begin shaping markets in advance of regulatory approval, often enhancing company value as a result.
This program will help innovators expand their thinking beyond the next fund raise and build longer-term value for stakeholders. Listen to two case studies of companies that invested in advance of product marketing, clearance and launch. Q&A time included.
What you will learn: